Minerva Surgical Inc
OTC:UTRS
Gross Margin
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
Peer Comparison
| Country | Company | Market Cap |
Gross Margin |
||
|---|---|---|---|---|---|
| US |
|
Minerva Surgical Inc
OTC:UTRS
|
890 USD |
Loading...
|
|
| US |
|
Abbott Laboratories
NYSE:ABT
|
199.2B USD |
Loading...
|
|
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
175.5B USD |
Loading...
|
|
| US |
|
Stryker Corp
NYSE:SYK
|
146.1B USD |
Loading...
|
|
| IE |
|
Medtronic PLC
NYSE:MDT
|
124.4B USD |
Loading...
|
|
| US |
|
Boston Scientific Corp
NYSE:BSX
|
111.8B USD |
Loading...
|
|
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
47.1B EUR |
Loading...
|
|
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
52.1B USD |
Loading...
|
|
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
52B USD |
Loading...
|
|
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
48.1B USD |
Loading...
|
|
| US |
|
GE Healthcare Technologies Inc
NASDAQ:GEHC
|
38.2B USD |
Loading...
|
Market Distribution
| Min | -24 813% |
| 30th Percentile | 28.9% |
| Median | 43% |
| 70th Percentile | 60.5% |
| Max | 10 905 714.3% |
Other Profitability Ratios
Minerva Surgical Inc
Glance View
Minerva Surgical, Inc. is a medical technology company, which engages in the research, development, manufacture, and commercialization of invasive solutions for uterine healthcare needs of women. The company is headquartered in Santa Clara, California and currently employs 157 full-time employees. The company went IPO on 2021-10-22. The firm has established a product line of commercially available, minimally invasive alternatives to hysterectomy, which are designed to address the most common causes of abnormal uterine bleeding (AUB) in most uterine anatomies. Its solutions can be used in a variety of medical treatment settings and aim to address the drawbacks associated with alternative treatment methods and to preserve the uterus by avoiding unnecessary hysterectomies. The firm offers a suite of products for the treatment of structural and non-structural causes of AUB in most uterine anatomies. Its devices are utilized by obstetrician-gynecologists (OB/GYNs) across a variety of medical treatment settings, including hospitals, ambulatory surgical centers (ASCs) and physician offices.
See Also
Gross Margin is calculated by dividing the Gross Profit by the Revenue.
The current Gross Margin for Minerva Surgical Inc is 54.2%, which is below its 3-year median of 54.8%.
Over the last 2 years, Minerva Surgical Inc’s Gross Margin has decreased from 58.6% to 54.2%. During this period, it reached a low of 54.2% on Dec 31, 2022 and a high of 58.6% on Dec 1, 2021.
